Schweikert emphasizes the need for investment to improve systems.
06/10/2015
https://congress.gov...
I can't express my level of disappointment in your opening statement.
I think we need to get back in the business of tracking these 501(c)(3)s.
We, right now, as a government, we give $16 billion a year to Big Pharma to buy down the price of insulin.
I have a fixation that the adoption of technology is the ultimate solution here.